Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ferric Derisomaltose
Therapeutic Area : Hematology
Study Phase : Approved
Sponsor : Zydus Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Acquisition
Zydus Buys Rights from Pharmacosmos to Sell Drug to Treat Anemia in India, Nepal
Details : MonoFerric injection having Ferric derisomaltose, is a rapid, single dose intravenous therapy used for the treatment of iron deficiency in adult patients when oral iron preparations are ineffective or cannot be used.
Brand Name : MonoFerric
Molecule Type : Small molecule
Upfront Cash : Undisclosed
September 09, 2022
Lead Product(s) : Ferric Derisomaltose
Therapeutic Area : Hematology
Highest Development Status : Approved
Sponsor : Zydus Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Acquisition
Lead Product(s) : Ferric Derisomaltose
Therapeutic Area : Hematology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Monofer® is the first of the latest generation of innovative IV irons to be made available to patients in the Chinese health care system and is expected to expand the use of IV irons across multiple therapeutic areas.
Brand Name : Monofer
Molecule Type : Small molecule
Upfront Cash : Not Applicable
January 29, 2021
Lead Product(s) : Ferric Derisomaltose
Therapeutic Area : Hematology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?